124 related articles for article (PubMed ID: 10224464)
21. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
[TBL] [Abstract][Full Text] [Related]
22. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
[TBL] [Abstract][Full Text] [Related]
23. Identification of a chymotrypsin-like proteinase in human mast cells.
Schechter NM; Choi JK; Slavin DA; Deresienski DT; Sayama S; Dong G; Lavker RM; Proud D; Lazarus GS
J Immunol; 1986 Aug; 137(3):962-70. PubMed ID: 2424994
[TBL] [Abstract][Full Text] [Related]
24. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
25. Human peripheral blood eosinophils express stem cell factor.
Hartman M; Piliponsky AM; Temkin V; Levi-Schaffer F
Blood; 2001 Feb; 97(4):1086-91. PubMed ID: 11159541
[TBL] [Abstract][Full Text] [Related]
26. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
27. Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart.
Li J; Lu H; Plante E; Meléndez GC; Levick SP; Janicki JS
J Mol Cell Cardiol; 2012 Oct; 53(4):469-74. PubMed ID: 22850284
[TBL] [Abstract][Full Text] [Related]
28. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.
Kokkonen JO; Vartiainen M; Kovanen PT
J Biol Chem; 1986 Dec; 261(34):16067-72. PubMed ID: 3536921
[TBL] [Abstract][Full Text] [Related]
29. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
30. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids.
Kim YK; Nakagawa N; Nakano K; Sulakvelidze I; Dolovich J; Denburg J
J Allergy Clin Immunol; 1997 Sep; 100(3):389-99. PubMed ID: 9314353
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural analysis of maturing human T and TC mast cells in situ.
Craig SS; Schechter NM; Schwartz LB
Lab Invest; 1989 Jan; 60(1):147-57. PubMed ID: 2642987
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
[TBL] [Abstract][Full Text] [Related]
33. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of mast cell characteristics in human myeloid cell lines.
Welker P; Grabbe J; Henz BM
Exp Dermatol; 2004 Sep; 13(9):535-42. PubMed ID: 15335353
[TBL] [Abstract][Full Text] [Related]
36. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells.
Feuser K; Feilhauer K; Staib L; Bischoff SC; Lorentz A
Mol Immunol; 2011 Jan; 48(4):546-52. PubMed ID: 21106245
[TBL] [Abstract][Full Text] [Related]
37. Extended cleavage specificities of mast cell proteases 1 and 2 from golden hamster: Classical chymase and an elastolytic protease comparable to rat and mouse MCP-5.
Thorpe M; Fu Z; Albat E; Akula S; de Garavilla L; Kervinen J; Hellman L
PLoS One; 2018; 13(12):e0207826. PubMed ID: 30521603
[TBL] [Abstract][Full Text] [Related]
38. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.
Xia HZ; Du Z; Craig S; Klisch G; Noben-Trauth N; Kochan JP; Huff TH; Irani AM; Schwartz LB
J Immunol; 1997 Sep; 159(6):2911-21. PubMed ID: 9300715
[TBL] [Abstract][Full Text] [Related]
39. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.
Gebhardt T; Lorentz A; Detmer F; Trautwein C; Bektas H; Manns MP; Bischoff SC
Gut; 2005 Jul; 54(7):928-34. PubMed ID: 15951536
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
He S; Gaça MD; McEuen AR; Walls AF
J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
